DUBLIN–(BUSINESS WIRE)–The “Synthetic
Biology Market – Growth, Trends, and Forecast (2019-2024)”
report has been added to ResearchAndMarkets.com’s
offering.
The synthetic biology market has witnessed a CAGR of nearly 20%.
There are certain factors propelling the growth of the market, including
increasing support from the government and private institutions,
increasing R&D investments in drug discovery, and the development and
declining cost of DNA sequencing and synthesizing.
The increasing involvement of government bodies, research institutes,
and large-scale organizations in synthetic biology research activities
is likely to support the market over the next few years. The governments
of various nations have been providing support for research on synthetic
biology, due to its wide applications.
There has been a lot of research studies and projects, running in
various countries with respect to synthetic biology that have tried to
tap various complexities in the genomes of organisms, and hence, have
helped in creating more effective and efficient therapies to treat them.
There has also been an increasing application of genome editing in
agriculture. Hence, with the increasing support from the government and
private institutions, the market is expected to increase during the
forecast period.
The synthetic biology technologies and products are also finding
significant usage in various application areas. Since the organisms
engineered with synthetic biology techniques are relatively reasonable,
owing to their use in various industrial applications, which also
translates in a reduction in the cost of research, the demand for these
techniques is increasing considerably across the world.
Genome Engineering is Expected to Hold the Highest Market
Share in the Technology Segment
Genome engineering has appeared as the most prominent technology
utilized in synthetic biotechnology. The researchers expect this
technology to continue to lead over the forthcoming years. In addition,
other factors, such as advances in CRISPR-toolbox and DNA synthesis
technologies, the need for rapid, cheap, multiplex modification of
genomes, and ongoing research activities are expected to drive the
growth of the genome engineering market during the forecast period.
Hence, with a wide range of applications for genome engineering, many
companies are investing in genome engineering, globally, as many
government entities are turning toward biomass and climate change.
North America is Expected to Dominate During the Forecast
Period
North America is estimated to account for the largest share in the
synthetic biology market due to factors, such as the increasing demand
for bio-based products, increased investments in synthetic biology
companies, and rising R&D funding for synthetic biology. The increasing
support from the government and private institutions and increasing R&D
investments in drug discovery and development are also major growth
factors expected to drive the market during the forecast period.
Competitive Landscape
The competitive analysis of the companies reveals that most of the
companies are concentrating on agreements followed by product launches
for the expansion of their business. The value chain of the product
manufacturing includes the steps that require collaborative efforts by
two or more companies and this is the key reason for agreements among
the companies.
Key Topics Covered
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Support from Government and Private Institutions
4.2.2 Increasing R&D Investments in Drug Discovery and Development
4.2.3 Declining Cost of DNA Sequencing and Synthesizing
4.3 Market Restraints
4.3.1 Bio-safety and Bio-security
4.3.2 Ethical Issues
4.3.3 Reimbursement Cuts Causing Pricing Pressure
4.4 Porter’s Five Forces Analysis
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Core Products
5.1.1.1 Synthetic DNA
5.1.1.2 Synthetic Genes
5.1.1.3 Synthetic Cells
5.1.1.4 XNA (Xeno Nucleic Acid)
5.1.1.5 Chassis Organisms
5.1.2 Enabling Products
5.1.2.1 DNA Synthesis
5.1.2.2 Oligonucleotide Synthesis
5.2 By Technology
5.2.1 Genome Engineering
5.2.2 DNA Sequencing
5.2.3 Bioinformatics
5.2.4 Biological Components and Integrated Systems
5.3 By Applications
5.3.1 Healthcare
5.3.2 Chemicals (Including Bio-Fuels)
5.3.3 Agriculture
5.3.4 Others (Biosecurity, R&D, Energy, and Environment)
5.4 Geography
5.4.1 North America
5.4.1.1 US
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 UK
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Amyris Inc.
6.1.2 E. I. Du Pont De Nemours and Company
6.1.3 Genscript
6.1.4 Integrated DNA Technologies Inc.
6.1.5 Intrexon Corporation
6.1.6 New England Biolabs Inc.
6.1.7 Novozymes A/S
6.1.8 Koninklijke DSM N.V.
6.1.9 Synthetic Genomics Inc.
6.1.10 Thermo Fisher Scientific Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/9osg6u
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Biotechnology